A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
GoHealth, Inc.
GOCO
$8M
Mkt Cap
$0.34
+0.00%
GoHealth, Inc. (GOCO) has a 5-year average return on invested capital (ROIC) of -10.7%. This is below average and may indicate limited pricing power.
GoHealth, Inc. (GOCO) has a market capitalization of $5M. It is classified as a small-cap stock.
GoHealth, Inc. (GOCO) does not currently pay a regular dividend.
GoHealth, Inc. (GOCO) operates in the Insurance Agents, Brokers & Service industry, within the Financials sector.
GoHealth, Inc. (GOCO) reported annual revenue of $799 million in its most recent fiscal year, based on SEC EDGAR filings.
GoHealth, Inc. (GOCO) has a net profit margin of -0.4%. The company is currently unprofitable.
GoHealth, Inc. (GOCO) generated $-35 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
GoHealth is a leading health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers’ peace of mind when making healthcare decisions so they can focus on living life. With a widely scalable end-to-end platform and substantial presence in the Medicare landscape, we believe we are uniquely positioned as a trusted partner to the 67.0 million Medicare-eligible Americans, as well as the 11,000 Americans becoming eligible each day, as they navigate one of life's most important purchasing decisions. For many of these consumers, enrolling in a health insurance plan is confusing and difficult, and seemingly small differences between health plans may lead to significant out-of-pocket costs or lack of access to critical providers and medicines. We aim to simplify the process by offering education, comparison guidance, transparency and choice.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 738M | 799M | 735M | 632M | 1.1B | 877M |
| Net Income | -199M | -2.9M | -63M | -149M | -189M | -44M |
| EPS | $-16.66 | $-0.66 | $-7.19 | $-17.72 | $-26.80 | $-3.30 |
| Free Cash Flow | 0 | -35M | 95M | 47M | -319M | -129M |
| ROIC | -38.4% | -0.4% | -9.7% | -19.2% | -18.6% | -5.7% |
| Gross Margin | - | 83.7% | 78.4% | 70.3% | 77.5% | 77.3% |
| Debt/Equity | 8.54 | 2.02 | 2.15 | 1.90 | 1.90 | 1.05 |
| Dividends/Share | $0.00 | - | $0.41 | - | - | - |
| Operating Income | -300M | -7.0M | -82M | -319M | -489M | -65M |
| Operating Margin | -40.7% | -0.9% | -11.1% | -50.4% | -46.1% | -7.4% |
| ROE | -291.9% | -1.2% | -27.4% | -55.3% | -53.6% | -11.6% |
| Shares Outstanding | 16M | 23M | 9M | 8M | 7M | 13M |
| Metric | ||||||
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 877M | 1.1B | 632M | 735M | 799M | 738M |
| Gross Margin | 77.3% | 77.5% | 70.3% | 78.4% | 83.7% | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -65M | -489M | -319M | -82M | -7.0M | -300M |
| Op. Margin | -7.4% | -46.1% | -50.4% | -11.1% | -0.9% | -40.7% |
| Net Income | -44M | -189M | -149M | -63M | -2.9M | -199M |
| Net Margin | -5.0% | -17.8% | -23.5% | -8.6% | -0.4% | -27.0% |
| Non-Recurring | 0 | 387M | 12M | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | -5.7% | -18.6% | -19.2% | -9.7% | -0.4% | -38.4% |
| ROE | -11.6% | -53.6% | -55.3% | -27.4% | -1.2% | -291.9% |
| ROA | -2.1% | -9.2% | -9.0% | -4.2% | -0.2% | -19.3% |
| Cash Flow | ||||||
| Op. Cash Flow | -114M | -299M | 61M | 109M | -22M | -68M |
| Free Cash Flow | -129M | -319M | 47M | 95M | -35M | 0 |
| Owner Earnings | -335M | -340M | 21M | 78M | -45M | -91M |
| CapEx | 15M | 20M | 14M | 14M | 14M | 0 |
| Maint. CapEx | 4.5M | 13M | 13M | 12M | 12M | 12M |
| Growth CapEx | 10M | 6.3M | 567K | 2.0M | 1.9M | 0 |
| D&A | 4.5M | 13M | 13M | 12M | 12M | 12M |
| CapEx/OCF | N/A | N/A | 22.2% | 12.6% | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 3.6M | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | 2.6% | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 216M | 27M | 27M | 20M | 11M | 11M |
| Debt Repayment | 0 | 4.1M | 2.7M | 0 | 33M | 33M |
| Balance Sheet | ||||||
| Net Debt | 256M | 586M | 494M | 407M | 446M | 550M |
| Cash & Equiv. | N/A | N/A | N/A | N/A | N/A | 32M |
| Long-Term Debt | 396M | 665M | 505M | 423M | 448M | 448M |
| Debt/Equity | 1.05 | 1.90 | 1.90 | 2.15 | 2.02 | 8.54 |
| Interest Coverage | -2.0 | -14.6 | -5.6 | -1.2 | -0.1 | -0.1 |
| Equity | 380M | 353M | 269M | 231M | 242M | 68M |
| Total Assets | 2.1B | 2.1B | 1.7B | 1.5B | 1.5B | 1.0B |
| Total Liabilities | 1.7B | 1.7B | 1.4B | 1.3B | 1.2B | 61M |
| Intangibles | 1.1B | 1.2B | 1.0B | 793M | 605M | 605M |
| Retained Earnings | -19M | -208M | -357M | -420M | -423M | -423M |
| Working Capital | 264M | 212M | 149M | 106M | 62M | 62M |
| Current Assets | 392M | 429M | 415M | 476M | 400M | 400M |
| Current Liabilities | 127M | 217M | 265M | 370M | 338M | 338M |
| Per Share Data | ||||||
| EPS | -3.30 | -26.80 | -17.72 | -7.19 | -0.66 | -16.66 |
| Owner EPS | -24.97 | -48.09 | 2.48 | 8.85 | -1.94 | -5.68 |
| Book Value | 28.36 | 49.98 | 32.03 | 26.26 | 10.51 | 4.24 |
| Cash Flow/Share | -8.51 | -42.32 | 7.26 | 12.41 | -0.94 | -11.63 |
| Dividends/Share | N/A | N/A | N/A | 0.41 | N/A | 0.00 |
| Shares Out. | 13.4M | 7.1M | 8.4M | 8.8M | 23.0M | 16.1M |
| Valuation | ||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | -0.0 |
| P/FCF | N/A | N/A | 1.8 | 1.3 | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 7.1 | 1.1 | 0.3 | 0.5 | 1.2 | 0.1 |
| Price/Sales | 3.2 | 0.9 | 0.2 | 0.2 | 0.3 | 0.0 |
| FCF Yield | -4.8% | -83.3% | 54.7% | 75.8% | -12.4% | N/A |
| Market Cap | 2.7B | 383M | 87M | 126M | 285M | 5.4M |
| Avg. Price | 211.40 | 138.43 | 15.38 | 15.46 | 10.92 | 0.34 |
| Year-End Price | 200.55 | 54.15 | 10.32 | 14.30 | 12.37 | 0.34 |
GoHealth, Inc. passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 77.4%. At current prices, the estimated annualized return to fair value is +4.3%.
GoHealth, Inc. (GOCO) has a debt-to-equity ratio of 2.02. This indicates higher leverage, which may increase financial risk.
GoHealth, Inc. (GOCO) reported earnings per share (EPS) of $-0.66 in its most recent fiscal year.
GoHealth, Inc. (GOCO) has a return on equity (ROE) of -1.2%. A negative ROE may indicate losses or negative equity.
GoHealth, Inc. (GOCO) has a 5-year average gross margin of 77.4%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 5 years of financial data for GoHealth, Inc. (GOCO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
GoHealth, Inc. (GOCO) has a book value per share of $10.51, based on its most recent annual SEC filing.